Managers / Q3 2021 · view latest →
Yong Rong (HK) Asset Management Ltd
CIK 0001738071 · UNIT 1702, 17/F, INFINITUS PLAZA, 199 DES VOEUX ROAD CENTRAL, SHEUNG WAN, K3, 000000 · 85236203247
Summary
Yong Rong (Hk) Asset Management Ltd reported $153M in U.S.-listed holdings across 14 positions for Q3 2021.
The portfolio is heavily concentrated: AMD alone accounts for 20.2% of reported value.
Compared with Q2 2021, the fund opened 7 new positions and exited 11.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 86.1% · $131M
- Other · 7.0% · $11M
- ADR · 6.9% · $11M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MARAMARATHON DIGITAL HOLDINGS IN | NEW | +420.0K | 420.0K | +$13M | $13M |
| AFRMAFFIRM HLDGS INC | NEW | +104.0K | 104.0K | +$12M | $12M |
| PRCTPROCEPT BIOROBOTICS CORP | NEW | +262.0K | 262.0K | +$10M | $10M |
| RXRXRECURSION PHARMACEUTICALS IN | NEW | +377.0K | 377.0K | +$9M | $9M |
| BBBYOVERSTOCK COM INC DEL | NEW | +75.0K | 75.0K | +$6M | $6M |
| GENETRON HLDGS LTD | NEW | +322.1K | 322.1K | +$4M | $4M |
| LEGNLEGEND BIOTECH CORP | NEW | +29.8K | 29.8K | +$2M | $2M |
| FUTUFUTU HLDGS LTD | SOLD OUT | −737.0K | 0 | −$132M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | AMDADVANCED MICRO DEVICES INChistory → | COM | 20.24% | $31M | 300.0K |
| 2 | NAGECHROMADEX CORPhistory → | COM NEW | 16.98% | $26M | 4.13M |
| 3 | FCXFREEPORT-MCMORAN INChistory → | CL B | 9.24% | $14M | 433.1K |
| 4 | MARAMARATHON DIGITAL HOLDINGS INhistory → | COM | 8.70% | $13M | 420.0K |
| 5 | AFRMAFFIRM HLDGS INChistory → | COM CL A | 8.12% | $12M | 104.0K |
| 6 | PRCTPROCEPT BIOROBOTICS CORPhistory → | COM | 6.55% | $10M | 262.0K |
| 7 | MUMICRON TECHNOLOGY INChistory → | COM | 6.05% | $9M | 130.0K |
| 8 | PDDPINDUODUO INChistory → | SPONSORED ADS | 5.94% | $9M | 100.0K |
| 9 | RXRXRECURSION PHARMACEUTICALS INhistory → | CL A | 5.69% | $9M | 377.0K |
| 10 | DLOCAL LTD | CLASS A COM | 4.08% | $6M | 114.0K |
| 11 | BBBYOVERSTOCK COM INC DELhistory → | COM | 3.83% | $6M | 75.0K |
| 12 | GENETRON HLDGS LTD | ADS | 2.92% | $4M | 322.1K |
| 13 | LEGNLEGEND BIOTECH CORP | SPONSORED ADS | 0.99% | $2M | 29.8K |
| 14 | PCTPURECYCLE TECHNOLOGIES INC | COM | 0.67% | $1M | 77.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $227M | 10 | May 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $330M | 23 | Jan 30, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $488M | 21 | Nov 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $415M | 18 | Aug 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $430M | 26 | Apr 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $231M | 24 | Feb 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $346M | 23 | Oct 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $291M | 17 | Jul 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $376M | 20 | May 2, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $266M | 16 | Feb 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $109M | 14 | Oct 19, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $228M | 21 | Jul 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $178M | 16 | Apr 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 15 | Jan 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $31M | 8 | Oct 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $128M | 18 | Jul 26, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $71M | 7 | May 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $127M | 16 | Feb 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $153M | 14 | Oct 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $402M | 18 | Aug 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $365M | 15 | May 6, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $371M | 16 | Feb 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $147M | 10 | Nov 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $114M | 14 | Aug 4, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $61M | 14 | Apr 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $75M | 14 | Feb 19, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $82M | 13 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $69M | 19 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $325M | 25 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $148M | 18 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.